$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
丙肝的传播途径与临床表现
2025-10-19 11:44:20
Check Details
如何预防和减少丙肝经血液传播?
2025-10-19 11:44:20
Check Details
急性丙肝的临床表现及检查
2025-10-19 11:44:20
Check Details
吉三代,治疗丙肝最佳选择
2025-10-19 11:44:20
Check Details
丙肝新药可改善颈动脉增厚
2025-10-19 11:44:20
Check Details
丙型肝炎病毒感染和心血管疾病风险
2025-10-19 11:44:20
Check Details
丙肝患者死亡风险比普通人群高3.1至6.7倍!
2025-10-19 11:44:20
Check Details
维生素D缺乏症与病毒性肝炎
2025-10-19 11:44:20
Check Details
丙肝的4大误区
2025-10-19 11:44:20
Check Details
干血斑法同时检测丙型肝炎和艾滋病
2025-10-19 11:44:20
Check Details
丙肝的3大特点
2025-10-19 11:44:20
Check Details
丙肝患者肝癌发生的风险因素
2025-10-19 11:44:20
Check Details
1
2
...
244
245
246
247
248
249
250
...
505
506
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
2
A Precision FGFR Inhibitor for Cholangiocarcinoma
3
Best time to take Luqu Bopa (Wenkedake) and precautions
4
Is defibrotide included in medical insurance?
5
When was defibrinoside launched on the market?
6
Will defibrination be reimbursed by medical insurance?
7
What conditions is defibrinoside suitable for treating?
8
What is the therapeutic effect of defibrotide?
9
How should defibrinoside be used?
10
What is the effect of defibrotide?
11
Defibrinoside Detailed Instructions
12
What is the effect of defibrination?